6 search results - page 1 / 2 » Robust SVM-Based Biomarker Selection with Noisy Mass Spectro... |
EVOW
2006
Springer
14 years 1 months ago
2006
Springer
Abstract. Computational analysis of mass spectrometric (MS) proteomic data from sera is of potential relevance for diagnosis, prognosis, choice of therapy, and study of disease act...
WILF
2007
Springer
14 years 4 months ago
2007
Springer
Abstract. Analysis and visualization of high-dimensional clinical proteomic spectra obtained from mass spectrometric measurements is a complicated issue. We present a wavelet based...
DILS
2007
Springer
14 years 22 hour ago
2007
Springer
The success of mass spectrometry-based proteomics in emerging applications such as biomarker discovery and clinical diagnostics, is predicated substantially on its ability to achie...
30
Voted
BMCBI
2010
13 years 10 months ago
2010
Background: As a novel cancer diagnostic paradigm, mass spectroscopic serum proteomic pattern diagnostics was reported superior to the conventional serologic cancer biomarkers. Ho...
CSDA
2008
13 years 10 months ago
2008
Mass spectrometry from clinical specimens is used in order to identify biomarkers in a diagnosis. Thus, a reliable method for both feature selection and classification is required...